HBCM
JAZZ icon

Heron Bay Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Heron Bay Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,447
Closed -$2.21M – 74
2021
Q2 		$2.21M Buy
12,447
+1,624
+15% +$281K 1.22% 31
2021
Q1 		$1.78M Buy
10,823
+408
+4% +$67.1K 1.06% 35
2020
Q4 		$1.72M Buy
+10,415
New +$1.55M 1.12% 36

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Heron Bay Capital Management's JAZZ Position: Q3 2021 in Review

Heron Bay Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 12,447 shares — an estimated $2.21M sold.

Heron Bay Capital Management first reported a position in JAZZ in Q4 2020 and held it in 3 quarters. The position peaked at $2.21M in Q2 2021. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

  • Heron Bay Capital Management reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Heron Bay Capital Management sold 12,447 Jazz Pharmaceuticals shares in Q3 2021, an estimated $2.21M.
  • Heron Bay Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Heron Bay Capital Management's Jazz Pharmaceuticals position peaked at $2.21M in Q2 2021.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Heron Bay Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.